| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/19/2004 | US6805880 Pharmaceutical delivery system for vitamin C and vitamin E and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stress |
| 10/19/2004 | US6805879 Made with a hydrophilic polymer; microencapsulation of proteins, peptides, viruses, bacteria, cells; diagnosis kits |
| 10/19/2004 | US6805878 Transdermal administration of ACE inhibitors |
| 10/19/2004 | US6805877 Intravaginal devices containing progesterone for estrus synchronization and related processes |
| 10/19/2004 | US6805876 For producing articles useful for implantation or injection into the human body |
| 10/19/2004 | US6805865 Compositions and methods for treating cancer and hyperproliferative disorders |
| 10/19/2004 | US6805857 Method of modulating factor D, factor H and CD4 cell immune response with a polystyrene sulfonate, alginate, and saline infusion solution |
| 10/19/2004 | US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 10/19/2004 | US6805853 Delivery of diazepam through an inhalation route |
| 10/19/2004 | US6805818 Apparatus and methods for forming patterned soft gelatin capsules |
| 10/19/2004 | US6805693 Infusion device and driving mechanism for same |
| 10/19/2004 | US6805687 Infusion pump with access regulator |
| 10/19/2004 | CA2338070C Diltiazem controlled release formulation and method of manufacture |
| 10/19/2004 | CA2171971C Multilayer halogen-free barrier film for ostomy and transdermal drug delivery applications |
| 10/19/2004 | CA2139929C Transdermal therapeutic system containing the active substance 17-.beta.-oestradiol (anhydrous) |
| 10/19/2004 | CA2075454C Melt cocrystallised sorbitol/xylitol compositions |
| 10/17/2004 | CA2463827A1 Methods and compositions for controlled release of bioactive compounds |
| 10/14/2004 | WO2004088029A2 Disposable, paper-based hospital and operating theater products |
| 10/14/2004 | WO2004087765A1 Titanium dioxide complex having molecule distinguishability |
| 10/14/2004 | WO2004087648A2 Stabilized phenytoin containing composition |
| 10/14/2004 | WO2004087307A1 Chitosan product, method for the production thereof, methods for producing chitosan product derivatives and compositions based thereon |
| 10/14/2004 | WO2004087237A2 Implantable medication delivery device using pressure regulator |
| 10/14/2004 | WO2004087213A1 Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| 10/14/2004 | WO2004087209A1 Preparation for sustaining therapeutically effective blood concentration of analgesic activity potentiator |
| 10/14/2004 | WO2004087204A2 Microfluidized oil-in-water emulsions and vaccine compositions |
| 10/14/2004 | WO2004087203A2 Immunostimulatory nucleic acid oil-in-water formulations for topical application |
| 10/14/2004 | WO2004087178A1 A formulation comprising a bacterial strain |
| 10/14/2004 | WO2004087175A1 Oral extended release compressed tablets of multiparticulates |
| 10/14/2004 | WO2004087174A1 Parenteral formulation of mycophenolic acid, a salt or prodrug thereof |
| 10/14/2004 | WO2004087146A1 Processes for production of fine particle mixtures |
| 10/14/2004 | WO2004087141A1 Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases |
| 10/14/2004 | WO2004087135A1 Oral suspension of tegaserod |
| 10/14/2004 | WO2004087126A1 Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
| 10/14/2004 | WO2004087121A2 Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases |
| 10/14/2004 | WO2004087115A2 Combination compositions of camptothecins and fluoropyrimidines |
| 10/14/2004 | WO2004087114A1 Capsules with delayed release of the capsule contents for oral administration |
| 10/14/2004 | WO2004087113A1 Pharmaceutical compositions for colon specific delivery |
| 10/14/2004 | WO2004087112A1 Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin |
| 10/14/2004 | WO2004087111A1 Oral taste masked pharmaceutical compositions |
| 10/14/2004 | WO2004087110A1 Scored tablet |
| 10/14/2004 | WO2004087109A1 Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis |
| 10/14/2004 | WO2004087108A1 Taste-masking vehicle for coated oxazolidinone particles |
| 10/14/2004 | WO2004087107A1 Cationic liposome targeting sebaceous glands |
| 10/14/2004 | WO2004087106A1 Method of controlling release speed of subject to be transported from liposome |
| 10/14/2004 | WO2004087105A1 Combination formulations of platinum agents and fluoropyrimidines |
| 10/14/2004 | WO2004087104A1 Pharmaceutical compositions containing active agents having a lactone group and transition metal ions |
| 10/14/2004 | WO2004087103A1 Ophthalmic drug delivery system using polymer micell |
| 10/14/2004 | WO2004087102A2 A process for preparing a pharmaceutical active ingredient with high specific surface area |
| 10/14/2004 | WO2004087101A2 Oral formulations of cladribine |
| 10/14/2004 | WO2004087100A2 Cladribine formulations for improved oral and transmucosal delivery |
| 10/14/2004 | WO2004087098A2 Preserved ophthalmic compositions |
| 10/14/2004 | WO2004087097A2 Stable liposomes or micelles comprising a sphinolipid and a peg-lipopolymer |
| 10/14/2004 | WO2004087096A1 Pharmaceutical compositions having reduced bitter taste |
| 10/14/2004 | WO2004087095A2 Osmotic controlled release device containing zafirlukast and an h1-antagonist |
| 10/14/2004 | WO2004087094A2 Nano-sized vehicles transporting a therapeutic agent and at least one drug resistance modulator for the treatment of multi drug resistance |
| 10/14/2004 | WO2004087071A2 Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection |
| 10/14/2004 | WO2004087052A2 Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent |
| 10/14/2004 | WO2004087045A2 Devices, methods, and compositions to prevent restenosis |
| 10/14/2004 | WO2004087043A2 Stable ophthalmic formulation containing an antibiotic and a corticosteroid |
| 10/14/2004 | WO2004086885A1 High intensity sweetner composition and delivery of same |
| 10/14/2004 | WO2004082658A1 Controlled release system containing saccharose acetate isobutyrate |
| 10/14/2004 | WO2004067508A3 Use of photodynamic therapy therapeutic agents entrapped in ceramic nanoparticles |
| 10/14/2004 | WO2004062552A3 Pharmaceutical composition containing a nsaid and a benzimidazole derivative |
| 10/14/2004 | WO2004060379A3 Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications |
| 10/14/2004 | WO2004057985A3 Snacks of orally soluble edible films |
| 10/14/2004 | WO2004052346A8 Pharmaceutical compositions containing indistinguishable drug components |
| 10/14/2004 | WO2004052238A3 Phototherapy bandage |
| 10/14/2004 | WO2004041303B1 Oral formulation or botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease |
| 10/14/2004 | WO2004041245B1 Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 10/14/2004 | WO2004040972A3 Radioisotope-associated polymeric hydrogel microspheres and methods for producing and using the same |
| 10/14/2004 | WO2004034890A3 Biological scaffolding material |
| 10/14/2004 | WO2004026118A3 Administration of free radical scavengers to prevent or treat ischemia-reperfusion injuries |
| 10/14/2004 | WO2004004798A3 Central airway administration for systemic delivery of therapeutics |
| 10/14/2004 | WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 10/14/2004 | WO2003101395A3 Formulations for amylin agonist peptides |
| 10/14/2004 | WO2002045733A3 Oral preprations having itching-relievign or antipruritic activity |
| 10/14/2004 | US20040204744 Apparatus and methods using acoustic telemetry for intrabody communications |
| 10/14/2004 | US20040204673 Modular infusion device and method |
| 10/14/2004 | US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
| 10/14/2004 | US20040204482 provides a defined blood concentration profile having no rapid initial rise in blood plasma concentration of the good soluble active substance when administered; (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide; nervous system, gastrointestinal, heart disorders, Alzheimer's |
| 10/14/2004 | US20040204479 Injectable composition |
| 10/14/2004 | US20040204475 Pharmaceutical combination |
| 10/14/2004 | US20040204474 Hypotensive agents; cardiovascular disorders |
| 10/14/2004 | US20040204468 Clear odorless liquid gel |
| 10/14/2004 | US20040204442 In an insoluble matrix, such as shellac, high molecular weight polyethylene glycol polyvinyl alcohol, lactic acid - glycolic acid copolymer or sugars. Particularly preferred compounds are: enrofloxacin, danofloxacin and sarafloxacin |
| 10/14/2004 | US20040204441 Nasal delivery of apomorphine |
| 10/14/2004 | US20040204440 Composition, device, and method for treating sexual dysfunction via inhalation |
| 10/14/2004 | US20040204439 Composition, device, and method for treating sexual dysfunction via inhalation |
| 10/14/2004 | US20040204438 such as N-[4-(4-amino-1H-imidazol[4,5-c]quinolin-1-yl)butyl]-5-(dimethylamino)-naphthalenesulfonamide; for induction of biosynthesis of cytokines; immunomodulators; antineoplastic agents |
| 10/14/2004 | US20040204399 Aerosolized decongestants for the treatment of sinusitis |
| 10/14/2004 | US20040204391 Applying onto healed wound a composition comprising a fluid, film-forming carrier, and subsequently hardening the carrier into a tangible membrane juxtaposed to the healed wound thereby reducing scarring or improving the appearance thereof |
| 10/14/2004 | US20040204354 An artificial LDL particle containing an outer phospholipid monolayer(contains at least one apolipoprotein) and a solid lipid core which contains at least one therapeutic agent |
| 10/14/2004 | US20040204343 Alcohol-free transdermal insulin composition and processes for manufacture and use thereof |
| 10/14/2004 | US20040203170 Methods for identification and verification |
| 10/14/2004 | US20040203075 which bind pancreatic beta cells (to secrete insulin) and encapsulate cells for transplantation/treatment of diabetes; solid phase synthesis; kits |
| 10/14/2004 | US20040202737 Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| 10/14/2004 | US20040202736 Method of ameliorating side-effects of SERMs |
| 10/14/2004 | US20040202729 for delivering sulfur containing compounds to skin and absorbing irritants in the skin; high sorption base is employed which comprises non-swelling clay, gum, swelling clay, silicon and combinations thereof; treatment of skin disorders |
| 10/14/2004 | US20040202722 Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
| 10/14/2004 | US20040202721 spray-drying a mixture of a therapeutic, prophylactic and/or diagnostic agent; carboxylic acid or salt; phospholipid; a multivalent salt and a solvent to produce particles having a tap density less than 0.4 g/cm3.; preparing dry-powders suitable for inhalation |